SOT THERAPY
SUPPORTIVE OLIGONUCLEOTIDE THERAPY
(SOT- Apoptosis Inducer)
PRE-REQUISITE TEST:
(Patient must have an R.G.C.C. ONCOCOUNT/R.G.C.C Oncotrace within the last 6 months.)
REQUIREMENT:
15-25 ml Blood
THERAPY PREPARATION:
10-15 Working days (from the day the sample reaches the lab)
POST-TREATMENT FOLLOW-UP:
Oncocount or Oncotrail are recommended after 3 months of the administration to evaluate CTCs’ number or their immunophenotype for the 1st year. Blood samples 20-25ML should be sent to the lab.
DESCRIPTION
SOT is a personalized therapy for cancer, viruses and pathogens including Lyme Disease. The SOT has the ability to bind to a specific gene of interest that controls the cancer cell or pathogen by disrupting the critical process that promotes its survival or growth. During this therapy, we analyze a patient’s blood and create a complementary oligonucleotide sequence designed to interrupt the cells’ survival or growth. RGCC SOTs are available to RGCC Network doctors. Please contact us to discuss your requirements.